Access cutting-edge cancer treatment through this clinical trial at a research site in Santa Rosa. Study-provided care at no cost to qualified participants.
Access cancer specialists in Santa Rosa at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cancer treatment provided free
The PROCEADE PanTumor study aims to investigate M9140 in multiple tumor types which express carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) and it is therefore designed as a matrix study. This study aims to assess the antitumor activity, tolerability, safety, and pharmacokinetics (PK) of M9140 as monotherapy or in combination treatments in adult participants with locally advanced/metastatic CEACAM5 expressing tumors. There will be 3 substudies under this Master Protocol that
Sponsor: EMD Serono Research & Development Institute, Inc.
Check if you qualify for this cancer clinical trial in Santa Rosa, CA
If you're searching for cancer treatment options in Santa Rosa, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Santa Rosa research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.